Dermatology

Medication adherence comes down to costDermatologists should discuss cost and insurance coverage concerns with patients to boost adherence to acne medication, researchers report in JAMA Dermatology.
The best and worst of acne treatment optionsPoor quality trials make assessing effects of non-pharmacological treatments in acne difficult, but based on the evidence, glycolic acid, amino fruit acid, intense pulsed light and diode laser are the most promising.
Are facial toners necessary?Not really, says Dr. Zoe Draelos in this month's Cosmetic Conundrums. Toners are present in most commercial skin care products, but originally it was intended as a cleanser.
Are polymer-based specialty cleansers milder?Cleansing is a profound mechanical and chemical skin event. The challenge is to achieve skin hygiene without damaging the skin barrier, but smart surfactants are not yet reality.
Gene identified as having a role in suppressing atopic dermatitisThe transcription factor "retinoid-related orphan receptor-alpha" (RORA) has been identified as a regulator of T regulatory (Treg) genes responsible for suppressing allergic skin inflammation, researchers report.
Less itch and more sleep with baricitinibA phase two study of adults with moderate-to-severe atopic dermatitis shows that once-daily oral Janus kinase (JAK) 1 and 2 inhibitor baricitinib relieved itch and improved sleep, a study shows.
Heart disease and mental health conditions more prevalent in psoriasisModerate-to-severe psoriasis and psoriatic arthritis patients are more likely than people without these conditions to have cardiovascular and mental comorbidities, as well as higher healthcare utilization and medical costs, primarily from pharmacy-related expenses, according to a recent retrospective study of U.S. Department of Defense patients.
The extent of affected body area in psoriasis may determine mortalityThe risk of death for adults with psoriasis that impacts more than 10 percent of body surface area is about 1.8 times greater than adults without psoriasis, according to a new study.
I prescribe drugs off-label. Am I in violation of FDA regulationsIn a CME session through your local dermatology society, a prominent drug company provides journal articles documenting the off-label use of one of their prescription pharmaceutical agents. You obtain CME credits, read the journal article and begin prescribing the off-label medication. Is the drug company in violation of the U.S. Food and Drug Administration (FDA) rulings? Are your actions acceptable?
AAD insights and takeawaysIn this article, Dr. Norman Levine sums up his takeaways from the American Academy of Dermatology annual meeting, beginning with a presentation by two physicians who addressed the difficulties of managing hidradenitis suppurativa, such as fixed dosing. He also addressed controversies associated with treatments for atopic dermatitis. Apparently, bleach baths are no better than regular baths in improving skin symptoms.